Lexicon Pharmaceuticals, Inc. (LXRX) Tops Q2 EPS by 1c
Tweet Send to a Friend
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) reported Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
